In this episode, we dive deep into the world of AI-driven drug development and clinical trials. We welcome 3 distinguished guest speakers: Guillaume Gigon, Vice President of Technology and AI at Innovaderm; Nardin Nakhla, Co-Founder and CTO of Simmunome; and Christian Dansereau, Founder and CEO of Perceiv AI. Our roundtable discussion explores the challenges and benefits of integrating AI into clinical research, with a focus on neurological, immune, and dermatological fields. We discuss how AI accelerates drug discovery and enhances trial efficiency through predictive analytics. Finally, we look ahead to the future of AI in managing clinical trials and the next steps for this transformative technology.